On the Etiology of Tropical Spastic Paraparesis and Human T-cell Lymphotropic
Virus-I-Associated Myelopathy
Vladimir Zaninovic, MD
Int J Infect Dis 1999; 3: 168-176.
The purpose of this review is to present some concepts on the etiology of tropical
spastic paraparesis or human T-cell lymphotropic virus-I (HTLV-I)-associated
myelopathy (TSP/HAM). The large number of syndromes that have been associated
with HTLV-I (60 to date), the existence of TSP/HAM cases associated with other
retroviruses (human immunodeficiency virus-2 [HIV-2], HTLV-II), the existence of
many TSPs without HTLV-I, and the evidence of clear epidemiologic contradictions
in TSP/HAM indicate that the etiopathogenesis of TSP/HAM is not yet clear.
Tropical spastic paraparesis/HAM affects patients of all human ethnic groups, but
usually in well localized and relatively isolated geographic regions where HTLV-I
has been endemic for a long time. Environmental factors and geographic locations
appear to be critical factors. Because the neuropathology of TSP/HAM suggests a
toxometabolic, rather than a viral cause, it is proposed that an intoxication similar to
neurolathyrism could account for some of TSP/HAM cases, mainly in tropical and
subtropical countries. If this were the case, HTLV-I could be a cofactor or act as a
bystander. it is possible that co-infection with another agent is necessary to produce
TSP/HAM and most of the syndromes associated with HTLV-I.
KEYWORDS: cofactors, environmental, HIV-1, HTLV-I, HTLV-I-associated myelopathy,
HTLV-II, myelopathy, tropical spastic paraparesis
Back to Table of Contents
The International Journal of Infectious Diseases is owned by
the International Society for Infectious Diseases.
The Journal is published quarterly for the ISID by B.C. Decker Inc.
|